← FDA DRUG APPROVALS

FDA ANDA · ANDA211815

FLUOCINOLONE ACETONIDE

Sponsor: GLENMARK PHARMS LTD

APPLICATION
ANDA211815
TYPE
ANDA
ORIGINAL APPROVAL
2018-12-14
LATEST ACTION
2025-01-24
ROUTE
AURICULAR (OTIC), OTIC
DOSAGE FORM
OIL/DROPS
MARKETING STATUS
Discontinued

Products

FLUOCINONIDE ACETONIDEDiscontinued
FLUOCINOLONE ACETONIDE 0.01% · OIL/DROPS · OTIC

Approval history

2025-01-24Labeling · Supplement 4 · standardAP
2018-12-14UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →